From: Impact of vitamin D status on CF and non-CF bronchiectasis outcomes
Non-CF bronchiectasis (group I) | CF bronchiectasis (group II) | Controls (group III) | P value | Post hoc | ||
---|---|---|---|---|---|---|
Serum vitamin D level, mean ± SD | 20.85±7.21 | 20.15±11.66 | 35.15±12.84 | <0.001● | (I vs III) ** (II vs III)** | |
Vitamin D level status, n (%) | Deficient | 9(45.0%) | 15(75.0%) | 2(10.0%) | <0.001# | (II vs III)** (I vs III)* |
Insufficient | 8(40.0%) | 4(20.0%) | 7(35.0%) | |||
Sufficient | 3(15.0%) | 1(5.0%) | 11(55.0%) | |||
Daily dietary intake of vitamin D (IU) (mean ± SD) | 338.50±62.17 | 313.80±65.66 | 357.25±40.54 | 0.063● | (II vs III) * | |
Vitamin D dietary intake % of RDA (mean ± SD) | 56.42±10.36 | 56.85±6.90 | 60.39±9.75 | 0.467● | ||
Sun exposure, N (%) | Adequate | 6 (30.0%) | 3 (15.0%) | 8 (40.0%) | 0.552# | |
Inadequate | 14 (70.0%) | 17 (85.0%) | 12 (60.0%) |